In vivo CRISPR screening identifies metastasis suppressors in triple-negative breast cancer
Researchers have utilized in vivo CRISPR/Cas9 screening to identify specific genes that act as metastasis suppressors in triple-negative breast cancer. The study highlights how the loss of these genes promotes tumor progression and suggests potential targets for future therapeutic intervention.
Why it matters
Identifying these suppressors provides critical insights into the mechanisms of cancer metastasis, which is the primary cause of cancer-related mortality.
Nature Communications ( 2026 ) Cite this article
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in